オプションチェーンは、Cara Therapeuticsの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Cara Therapeuticsの市場センチメントを評価します。.

Cara Therapeutics (NASDAQ:CARA) 株価情報, オプションチェーン

Cara Therapeutics

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

Cara Therapeutics Inc

Carasent AB (publ)

Caravan Energy Corp Ordinary Shares

Carawine Resources Ltd

Get all portfolios for currently logged in user. Filter using {$pid}.

Search for authors by name. Accepts partials. You may limit the amount by using {$limit}. Default limit is 20.

Get list of channels and subscription status.

Update subscription status for channel with ID {$channel_id}.

Authentication and manipulation of user data.

Authenticate a user, set auth_type to "key" to receive a login key instead of a session cookie.

Request new password link. Identification can be username or email address.

Logout user from API. Expects the HTTP_X_DEVICE_KEY header to correctly logout.

Get list of devices for currently logged in user.

Remove access for device with {$did}. Different from device key!

Remove access for a device using the device key {$key}.

Receive the profile information for the currently logged in user.

Update profile of the currently logged in user.

Get the settings for the currently logged in user, currently only returns email.

Press Releases

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NURO, CARA, ZUO, BMTX on Behalf of Shareholders

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Cara Therapeutics, Inc. - CARA

News

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NURO, CARA, ARCH on Behalf of Shareholders

Kuehn Law Encourages VOXX, CARA, VTS, and HURA Investors to Contact Law Firm

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, NURO, PWOD, CARA on Behalf of Shareholders

Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split

CARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cara Therapeutics, Inc. - CARA

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ML, PWOD, NURO, CARA on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of Shareholders

ARCH

BLUE

BMTX

CARA

CYTH

HURA

NURO

PDCO

PWOD

VOXX

AN2 Therapeutics

Athira Pharma

CalciMedica

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Cingulate

Cocrystal Pharma

Citius Pharmaceuticals, Inc. - Common Stock

Citius Pharmaceuticals

Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics

Dare Bioscience

Durect

Gelteq

Hoth Therapeutics

Impact BioMedical

IGC Pharma

Opus Genetics

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences

Lexaria Bioscience

Lipocine

Lyra Therapeutics

MIRA Pharmaceuticals, Inc. - Common Stock

Comments

Cara Therapeutics

Cara Therapeutics (CARA) オプション

Cara Therapeutics (NASDAQ:CARA) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル